
“Sleep Inertia in Idiopathic Hypersomnia or Narcolepsy in a Phase 4 Study”
Wednesday, December 16 at 12:00pm – 1:00pm ET
Overview: Idiopathic hypersomnia and narcolepsy are chronic central disorders of hypersomnolence with debilitating symptoms that impact patients 24-hours a day. In this webinar, we will explore the symptom burden of these sleep disorders, and sleep inertia in particular. We will also discuss innovative approaches for assessing sleep inertia in idiopathic hypersomnia and narcolepsy and explore similarities and differences in the clinical presentation and characteristics of sleep inertia in these patient populations.
Learning Outcomes
- Review the 24-hour symptom burden of idiopathic hypersomnia and narcolepsy
- Introduce approved indications and key safety information for a treatment for idiopathic hypersomnia and 2 key symptoms of narcolepsy
- Discuss novel methods for evaluating sleep inertia in idiopathic hypersomnia and narcolepsy
- Explore sleep inertia findings from a Phase 4 study
Speakers:
Deborah Nichols, M.S.
Director, Clinical Scientist in Neuroscience Medical Affairs at Jazz Pharmaceuticals
Hans P. A. Van Dongen, PhD
Professor, Dept. of Translational Medicine & Physiology, Washington State University Spokane
The SRSF and the SRS do not endorse any products discussed in this session.
Complimentary, Advanced Registration is Required. A recording of the webinar will be available at a later date.